Process for preparing inhibitors of nucleoside metabolism

Details Process for preparing inhibitors of nucleoside metabolism Process for preparing inhibitors of nucleoside metabolism

2007-03-09

2008-07-29

Shameem, Golam M (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

C544S224000, C544S242000, C548S530000, C548S531000, C548S532000

Reexamination Certificate

active

07405297

ABSTRACT:
A process of preparing a compound of the formula (I)wherein B is chosen from OH, NH2, NHR, H or halogen; D is chosen from OH, NH2, NHR, H halogen or SCH3; R is an optionally substituted alkyl, aralkyl or aryl group; and Z is selected from OH, hydrogen, halogen, hydroxy, SQ or OQ, Q is an optionally substituted alkyl, aralkyl or aryl group; or a tautomer thereof; or a pharmaceutically acceptable salt thereof; or an ester thereof; or a prodrug thereof,which comprises reacting a compound of the formula (II)with an anion produced by abstraction of the bromine or iodine atom from a compound of formula (XIX),to form a compound of formula (XX)The compound of formula (XX) is N- and O-deprotected to obtain the compound of formula (I).

REFERENCES:
patent: 5985848 (1999-11-01), Furneaux et al.
patent: 6066722 (2000-05-01), Furneaux et al.
patent: 6228847 (2001-05-01), Furneaux et al.
patent: 6379911 (2002-04-01), Schramm et al.
patent: 6458799 (2002-10-01), Montgomery et al.
patent: 6492347 (2002-12-01), Furneaux et al.
patent: 6583154 (2003-06-01), Norman et al.
patent: 6693193 (2004-02-01), Furneaux et al.
patent: 6764829 (2004-07-01), Schramm et al.
patent: 6803455 (2004-10-01), Furneaux et al.
patent: 7022852 (2006-04-01), Furneaux et al.
patent: 7098334 (2006-08-01), Furneaux et al.
patent: 7109331 (2006-09-01), Furneaux et al.
patent: 7211653 (2007-05-01), Furneaux et al.
patent: 7211677 (2007-05-01), Furneaux et al.
patent: 2006/0160765 (2006-07-01), Evans et al.
patent: 2006/0217551 (2006-09-01), Evans et al.
patent: WO 94/11534 (1994-05-01), None
patent: WO 99/19338 (1999-04-01), None
patent: WO 2004/018496 (2004-03-01), None
patent: WO 2005/118532 (2005-12-01), None
patent: WO 2006/014913 (2006-02-01), None
patent: WO 2006/123953 (2006-11-01), None
patent: WO 2007/069923 (2007-06-01), None
patent: WO 2007/097647 (2007-08-01), None
patent: WO 2007/097648 (2007-08-01), None
Banker G S et al., entitled “Modern Pharmaceutics,” Marcel Dekker Inc., Third Edition, Revised and Expanded, 1996, pp. 451 & 596.
“Biocryst Pharmaceuticals, Inc. Announces Preliminary Phase II Trial Data for a Topical Ointment formulation of PNP Drug Drug Candidate, BCX-34,” Biocryst News, Apr. 29, 1998.
Evans G B et al., entitled “Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase,” J. Med. Chem. 2003, 46, 3412-3423.
Evans G B et al. “Synthesis of a transition state analogue inhibitor of purine nucleoside phosphorylase via the Mannich reaction,” Organic Letters 2003, 5(20), 3639-3640.
Filichev V V et al., entitled “Synthesis of 1′-aza-C-nucleosides from (3R,4R)-4-(hydroxymethyl)pyrrolidin-3-ol,” Tetrahedron 57 (2001) 9163-9168.
Galeazzi, R et al., “Chiral 3-hydroxypyrrolidin-2-ones from a Baylis-Hillman adduct: convergent, stereoselective synthesis of a glycosidase inhibitor,” Tertrahedron: Asymmetry, 2004 vol. 15 pp. 3249-3256.
Kamath V P et al., entitled “Synthesis of a potent transition-state inhibitor of 5′-Deoxy-5′-methylthioadenosine phosphorylase,” J. Med. Chem. 2004, 47, 1322-1324.
Kametani, T et al., “Studies on the Syntheses of Heterocyclic Compounds. 762. Synthesis of 3-benzyl-6-methyl-2-oxo-3,6-diazabicyclo[3.1.0]hexane as a synthetic intermediate of mitomycins,” Tetrahedron, 1979, 35(3), pp. 313-316.
Karlsson S et al., entitled “Synthesis of enantiomerically pure 4-substituted pyrrolidin-3-ols via asymmetric 1,3-dipolar cycloaddition,” Tetrahedron: Asymmetry 12 (2001) 1977-1982.
Lewandowicz A et al., entitled “Over-the barrier transition state analoques and crystal structure withMycobacterium tubersulosispurine nucleoside phosphorylase,” Biochemistry 2003, 42, 6057-6066.
Lewandowicz A et al. “Energetic Mapping of Transition State Analogue Internations with Human andPlasmodium falciparumPurine Nucleotide Phosphorylases” Journal of Biological Chemistry, 2005, 280(34), 30320-30328.
STN File CA Abstract No. 91-123648 (2005.
Wolff M E, entitled “Burger's Medicinal Chemistry and Drug Discovery,” Fifth Edition, vol. 1: Principles and Practice, John Wiley & Sons, 1995, 975-977.
Braunheim, B.B. et al., “Prediction of Inhibitor Binding Free Energies by Quantum Neural Networks. Nucleoside Analogues Binding to Trypanosomal Nucleoside Hydrolase”. Biochemistry, Nov. 12, 1999, vol. 38, No. 49, 16076-16083.
Miiles, R.W. et al., “Iminoribitol Transition State Analogue Inhibitors of Protozoan Nucleoside Hydrolases”. Biochemistry, Sep. 11, 1999, vol. 38, No. 40, 13147-13154.
Shi, W. et al., “The 2.0 Ang Structure of Malarial Purine Phosphoribosyltransferase in Complex with a Transition State Analogue Inhibitor”. Biochemistry, Jul. 13, 1999, vol. 38, No. 31, 9872-9880.
Li, C. et al., “Transition-State Analogs as Inhibitors of Human and Malarial Hypoxanthine-guanine Phosphoribosyltransferases”. Nat. Struct. Biol., 1999, vol. 6, No. 6, 582-587.
Miles, R. W. et al., “Purine Nucleoside Phosphorylase. Transition State Structure, Transition State Inhibitors and One-Third-The-Sites Reactivity”. Biomed. Health Res. Series, vol. 27 (Enzymatic Mechanisms, Frey & Northrop, eds), 32-47, 1999. IOS Press.
Furneaux, R.H. et al., “Improved Synthesis of 3H,5H-Pyrrolo[3,2,-d] pyrimidines”. J. Org. Chem, 1999, vol. 64, No. 22, 8411-8412.
Miles, R.W. et al., “One-Third-The-Sites Transition-State Inhibitors for Purine Nucleoside Phosphorolase”. Biochemistry, 1998, vol. 37, No. 24, 8615-8621.
Elliot, A. J. et al., “A Short, Facile Sythesis of 2-aminio-1,5-dihydro-4H-pyrrolo[3,2-d]-pyrimidin-4-one (9-deazaguanine)”. Tetrahedron Lett., 1996, vol. 37, No. 25, 4339-43.
Brakta, M. et al., “Efficient Synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one”. J, Chem. Soc., Perkin Trans. 1, 1992, vol. 15, 1883-1884.
Taylor, E. C. et al., entitled “An Expeditious Synthesis of 2-Amino- 4(3H)-oxo-5H-pyrrolo [3, 2-d] pyrimidine (9-Deazaguanine)” Tetrahedron Letters, vol. 34, No. 29, 1993, pp. 4595-4598.
Lim M-I et al., entitled “A New Synthesis of Pyrrolo[3, 2-d]pyrimidines (“9- Deazapurines”) via 3-Amino-2-carboalkoxypyrroles” Journal of Organic Chemistry, vol. 44, No. 22, Oct. 26, 1979, pp. 3826-3829.
Lim, Mu-III et al., entitled “Synthesis of “9-deazaguanosine” and other new pyrrolo [3, 2-d] pyrimidine C-nucleosides” J. Org. Chem. (1983), 48(6), 780-8.
Elliott, Arthur J. et al., entitled “An Improved Synthesis of 7-substituted Pyrrolo [3, 2-d]pyrimidines” Journal of Organic Chemistry (1997), 62(23), 8071-8075.
Ciller, Juan A. et al., “Ring Transformation of Isoxazoles into Furan and Pyran Derivatives” J. Chem. Soc. Perkin Trans. I, 1985, pp. 2581-2584.
Furneaux, R. H. et al., entitled “Synthesis of Transition State Inhibitors for N-Riboside Hydrolases and Transferases,” Tetrahedron, vol. 53, No. 8, pp. 2915-2930, 1997.

Affiliated with

Also associated with

Rating

Process for preparing inhibitors of nucleoside metabolism does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for preparing inhibitors of nucleoside metabolism, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing inhibitors of nucleoside metabolism will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3972986